Author | Yasuhiro Funahashi, MD | OncLive

Author | Yasuhiro Funahashi, MD

Articles

Dr. Funahashi on Enhanced Activity With Lenvatinib/Everolimus Combo in RCC

May 27, 2016

Video

Yasuhiro Funahashi, MD, senior director, Eisai, discusses a study exploring the enhanced antitumor activity with the combination of lenvatinib (Lenvima) and everolimus (Afinitor) in patients with renal cell carcinoma (RCC).

x